These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 33355622
1. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer. Wu H, Li F, Zhu R. Acta Biochim Biophys Sin (Shanghai); 2021 Mar 02; 53(3):304-316. PubMed ID: 33355622 [Abstract] [Full Text] [Related]
2. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer. Liu C, Ren Q, Deng J, Wang S, Ren L. Biomed J; 2024 Aug 02; 47(4):100664. PubMed ID: 37774794 [Abstract] [Full Text] [Related]
5. CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p. Li M, Wang Q, Zhang X, Yan N, Li X. Cell Cycle; 2021 Jul 02; 20(13):1279-1294. PubMed ID: 34097560 [Abstract] [Full Text] [Related]
6. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer. Liang X, Zhang Z, Wang L, Zhang S, Ren L, Li S, Xu J, Lv S. Bioengineered; 2021 Dec 02; 12(2):10023-10036. PubMed ID: 34666602 [Abstract] [Full Text] [Related]
9. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression. Li S, Lu X, Zheng D, Chen W, Li Y, Li F. J Cancer Res Clin Oncol; 2022 Dec 02; 148(12):3485-3499. PubMed ID: 35907010 [Abstract] [Full Text] [Related]
11. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer. Liu J, Jiang K. J Cell Mol Med; 2022 May 02; 26(9):2505-2519. PubMed ID: 35348293 [Abstract] [Full Text] [Related]
12. METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells. Zhang QC. Kaohsiung J Med Sci; 2023 Mar 02; 39(3):266-277. PubMed ID: 36546578 [Abstract] [Full Text] [Related]
13. Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox. Zhou Y, Li W. Environ Toxicol; 2024 Mar 02; 39(3):1631-1640. PubMed ID: 38018881 [Abstract] [Full Text] [Related]
15. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W. Theranostics; 2019 Mar 02; 9(7):2036-2055. PubMed ID: 31037155 [Abstract] [Full Text] [Related]
16. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, Wei JF, Yang H. Mol Cancer; 2019 Jun 22; 18(1):110. PubMed ID: 31228940 [Abstract] [Full Text] [Related]
17. MiR-1827 functions as a tumor suppressor in lung adenocarcinoma by targeting MYC and FAM83F. Fan G, Xu P, Tu P. J Cell Biochem; 2020 Feb 22; 121(2):1675-1689. PubMed ID: 31595558 [Abstract] [Full Text] [Related]
18. METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer. Jing L, Lan L, Mingxin Z, Zhaofeng Z. Sci Rep; 2022 Oct 06; 12(1):16715. PubMed ID: 36202872 [Abstract] [Full Text] [Related]
19. miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2. Bu L, Tian Y, Wen H, Jia W, Yang S. Acta Biochim Biophys Sin (Shanghai); 2021 Feb 04; 53(2):189-200. PubMed ID: 33332541 [Abstract] [Full Text] [Related]
20. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Du M, Zhang Y, Mao Y, Mou J, Zhao J, Xue Q, Wang D, Huang J, Gao S, Gao Y. Biochem Biophys Res Commun; 2017 Jan 22; 482(4):582-589. PubMed ID: 27856248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]